Back to search

United States· US:0268-0110_6d7a39b8-39cd-4256-a4ba-5978b391037e

CENTER-AL - ARTEMISIA VULGARIS POLLEN

A medicinal product containing artemisia vulgaris pollen, registered in United States by ALK-Abello, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCENTER-AL - ARTEMISIA VULGARIS POLLENATC—REGISTER NO.US:0268-0110_6d7a39b8…PACKS LISTED1CHECKEDJune 3, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ARTEMISIA VULGARIS POLLEN
Manufacturer
ALK-Abello, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    0268011030
    30 mL in 1 VIAL, MULTI-DOSE (0268-0110-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Artemisia vulgaris pollen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All artemisia vulgaris pollen products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Beifuß Bencard Allergie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/837f8826-3520-457f-9dff-db35d0fd0fa0
GET /v1/drugs/837f8826-3520-457f-9dff-db35d0fd0fa0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "productid": "0268-0110_6d7a39b8-39cd-4256-a4ba-5978b391037e",
  "productndc": "0268-0110",
  "dosage_form": "INJECTION, SUSPENSION",
  "dea_schedule": null,
  "product_type": "NON-STANDARDIZED ALLERGENIC",
  "substance_name": "ARTEMISIA VULGARIS POLLEN",
  "proprietary_name": "CENTER-AL - ARTEMISIA VULGARIS POLLEN",
  "active_ingred_unit": "[PNU]/mL",
  "application_number": "BLA103753",
  "marketing_category": "BLA",
  "nonproprietary_name": "ARTEMISIA VULGARIS POLLEN",
  "start_marketing_date": "19750115",
  "active_numerator_strength": "10000"
}

See everything about artemisia vulgaris pollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.